Optimizing Small Batch Size To Solve Formulation Challenges

Summary: It is common to have a limited amount of API in the early phase of drug development, which impedes the rapid progression of drug development. Catalent has developed a new approach that enables the use of industrial scale machines from the very beginning and can result in manufacturing cGMP batches with good yields.

Click here to download technical note.